As GLP-1 receptor agonists continue to be widely adopted for obesity and metabolic disease, it is essential to consider their broader implications for bone health and orthopedic surgery
and has been licensed to Nasdaq for use in the name of the UK Index
These include: GLP-1 weight loss drugs explained Compare Mounjaro, Wegovy, Zepbound How GLP-1s work for weight loss and diabetes Side effects, safety and monitoring Dietary Recommendations Limit sulfur-rich foods (broccoli, cabbage, garlic, eggs)
doi: 10.1111/imr.12891 59 PrezSRius-PrezS
Limitations to keep in mind This was a genome-wide association study, not a randomised controlled trial
Cardiovascular Risk Must Drive Treatment Decisions Instead of starting with glucose alone, physicians should now prioritize therapies that lower cardiovascular risk in high-risk patients